State Board of Administration of Florida Retirement System lowered its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Rating) by 28.9% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,059 shares of the medical instruments supplier’s stock after selling 430 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in Mesa Laboratories were worth $216,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of MLAB. Principal Financial Group Inc. raised its holdings in shares of Mesa Laboratories by 24.3% in the 1st quarter. Principal Financial Group Inc. now owns 112,752 shares of the medical instruments supplier’s stock valued at $28,738,000 after purchasing an additional 22,017 shares in the last quarter. Royce & Associates LP grew its position in shares of Mesa Laboratories by 4.1% in the 1st quarter. Royce & Associates LP now owns 356,643 shares of the medical instruments supplier’s stock worth $90,901,000 after buying an additional 13,885 shares during the last quarter. State of New Jersey Common Pension Fund D purchased a new position in shares of Mesa Laboratories in the 2nd quarter worth approximately $2,185,000. Granahan Investment Management LLC grew its position in shares of Mesa Laboratories by 22.8% in the 1st quarter. Granahan Investment Management LLC now owns 57,267 shares of the medical instruments supplier’s stock worth $14,596,000 after buying an additional 10,649 shares during the last quarter. Finally, SG Americas Securities LLC purchased a new position in shares of Mesa Laboratories in the 2nd quarter worth approximately $2,159,000. Institutional investors own 92.70% of the company’s stock.
Mesa Laboratories Stock Performance
Shares of NASDAQ MLAB opened at $184.15 on Tuesday. The company has a current ratio of 2.80, a quick ratio of 2.13 and a debt-to-equity ratio of 0.53. Mesa Laboratories, Inc. has a 12 month low of $114.21 and a 12 month high of $333.42. The company has a 50 day simple moving average of $147.21 and a two-hundred day simple moving average of $180.16. The stock has a market cap of $982.81 million, a price-to-earnings ratio of -242.30 and a beta of 0.60.
Mesa Laboratories Announces Dividend
Insider Buying and Selling at Mesa Laboratories
In related news, Director John Bradley Schmieder sold 2,500 shares of the business’s stock in a transaction on Friday, November 11th. The shares were sold at an average price of $175.45, for a total value of $438,625.00. Following the completion of the transaction, the director now directly owns 68,976 shares in the company, valued at approximately $12,101,839.20. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 5.50% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts have recently issued reports on MLAB shares. StockNews.com raised shares of Mesa Laboratories from a “sell” rating to a “hold” rating in a research report on Friday, November 4th. Evercore ISI boosted their target price on shares of Mesa Laboratories to $166.00 in a research report on Tuesday, November 15th.
Mesa Laboratories Profile
Mesa Laboratories, Inc develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries.
- Get a free copy of the StockNews.com research report on Mesa Laboratories (MLAB)
- Three Ways To Win The Online Gambling Industry
- Santa Claus Rally? Here’s What Needs to Happen
- Is Ardelyx is A Buy After Slip in Early 2022
- Will the Return of Bob Iger Return the Magic to Disney Stock?
- Is Tesla A Bargain Now As It Trades At Two-Year Lows?
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.